Disclosure under Reg. 30(5) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Sanofi India Ltd has informed BSE regarding Disclosure under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sanofi and Innate Pharma collaborate
Research collaboration and licensing agreement for new bispecific antibodies will use Innate Pharmas and Sanofis technology to target tumour cells Sanofi and Innate Pharma have entered into a research collaboration and licensing agreement to apply Innate Pharmas new proprietary technology to the development of innovative bispecific antibody formats engaging natural killer (NK) cells to kill []
Jubilant Biosys, Sanofi partner to develop medicines for metabolic disorders
Collaboration aims at discovery and development of small molecule Inhibitors through phase I proof of mechanism in metabolic disorders Glenmark gets tentative USFDA nod for Sanofi's generic Multaq
However, the company cannot sell the product in the US as it is involved in a patent litigation with Sanofi Sanofi submits new diabetes drug application to US regulator
Sanofi said that it had submitted an application to the USFDA for a single daily insulin injection to treat adults with type 2 diabetes.
Sanofi aims for top spot in consumer health via asset swap
The French firm is offering its animal health unit in exchange for Boehringers consumer health, or non-prescription drugs, business plus 4.7 billion in cash Clarifies on News Item
With reference to news reported in Business Standard on December 11, 2015- "Sanofi Pasteur in talks to bring first dengue vaccine to India", Sanofi India Ltd has submitted to BSE a copy of Clarification. Clarification sought from Sanofi India Ltd
The Exchange has sought clarification from Sanofi India Ltd on December 11, 2015 with reference to news reported in Business Standard on December 11, 2015- "Sanofi Pasteur in talks to bring first dengue vaccine to India"The reply is awaited. Sanofi Pasteur in talks to bring first dengue vaccine to India
The French drug maker has its vaccine approved in Mexico for all four serotypes for patients aged 9 to 45 Sanofi launches injectable polio vaccine in India
Vaccine will be manufactured by Hyderabad-based Shantha Biotechnics Private Limited